SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-001875
Filing Date
2023-08-14
Accepted
2023-08-14 16:03:55
Documents
67
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrkr-20230630x10q.htm   iXBRL 10-Q 1390181
2 EX-31.1 mrkr-20230630xex31d1.htm EX-31.1 14105
3 EX-31.2 mrkr-20230630xex31d2.htm EX-31.2 14381
4 EX-32.1 mrkr-20230630xex32d1.htm EX-32.1 6699
5 EX-32.2 mrkr-20230630xex32d2.htm EX-32.2 6778
6 GRAPHIC mrkr-20230630x10q001.jpg GRAPHIC 9834
7 GRAPHIC mrkr-20230630x10q003.jpg GRAPHIC 79221
  Complete submission text file 0001410578-23-001875.txt   6118667

Data Files

Seq Description Document Type Size
8 EX-101.SCH mrkr-20230630.xsd EX-101.SCH 42853
9 EX-101.CAL mrkr-20230630_cal.xml EX-101.CAL 39020
10 EX-101.DEF mrkr-20230630_def.xml EX-101.DEF 194589
11 EX-101.LAB mrkr-20230630_lab.xml EX-101.LAB 358731
12 EX-101.PRE mrkr-20230630_pre.xml EX-101.PRE 294495
61 EXTRACTED XBRL INSTANCE DOCUMENT mrkr-20230630x10q_htm.xml XML 952054
Mailing Address 4551 KENNEDY COMMERCE DR. HOUSTON TX 77032
Business Address 4551 KENNEDY COMMERCE DR. HOUSTON TX 77032 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37939 | Film No.: 231169678
SIC: 2834 Pharmaceutical Preparations